<p>在 2025 年 10 月，全球市場正面臨一個複雜的局面，特點是美國通脹低於預期、國債收益率波動，以及歐元區和中國等關鍵地區的商業活動增強。在這些發展中，投資者越來越關注內部持股比例高的成長型公司，作為在不確定經濟環境中尋求穩定和韌性的潛在途徑。</p>
<h3>全球內部持股比例高的十大成長型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>鋭明技術 (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.9%</td>
<td>43.9%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34.2%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>69.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>49.6%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們篩選出的 819 只內部持股比例高的快速成長全球公司的完整名單。</p>
<p>以下是我們篩選出的部分股票。</p>
<h2>江蘇微導納米設備科技 (SHSE:688147)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 江蘇微導納米設備科技有限公司專注於製造高端微納米設備，服務於半導體及泛半導體行業，市值為 244 億元人民幣。</p>
<p><strong>運營：</strong> 公司通過設備製造部門產生收入，專注於半導體及泛半導體領域的高端微納米設備。</p>
<p><strong>內部持股比例：</strong> 18.7%</p>
<p>江蘇微導納米設備科技展現出強勁的增長潛力，預計未來三年收益將顯著增長。公司的收入預計將以 22.7% 的年率增長，超過中國市場的平均水平。儘管市盈率高達 68.7 倍，但仍低於半導體行業的平均水平 80.6 倍。最近的財務表現顯示出顯著改善，2025 年上半年淨收入從去年的 4285 萬元上升至 1.9236 億元，突顯出其在股價波動和完成總計 7953 萬元的股票回購中的增長軌跡。</p>
<ul>
<li>通過我們的綜合分析師估計報告深入瞭解江蘇微導納米設備科技的複雜性。</li>
<li>我們最近的估值報告指出，江蘇微導納米設備科技的股票在市場上可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688147 截至 2025 年 10 月的收益和收入增長</p>
<h2>北京君正半導體有限公司 (SZSE:300223)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 北京君正半導體有限公司專注於集成電路芯片產品的研發、設計和銷售，業務覆蓋中國及國際市場，市值為 434.2 億元人民幣。</p>
<p><strong>運營：</strong> 北京君正半導體有限公司通過在國內外市場的集成電路芯片產品的研發、設計和銷售產生收入。</p>
<p><strong>內部持股比例：</strong> 16%</p>
<p>北京君正半導體有限公司展現出潛力，預計收益將以 26.43% 的年率顯著增長，超過中國市場的平均水平。然而，其股價近期波動較大。儘管如此，最近對公司章程的修訂和在香港進行 H 股發行的計劃表明了戰略增長的舉措。公司的 2025 年半年度財務數據顯示，收入和淨收入分別小幅增長至 22.5 億元和 2.0312 億元，表明在這些發展中的穩定表現。</p>
<ul>
<li>在我們的收益增長報告中更深入地瞭解北京君正半導體有限公司的潛力。</li>
<li>我們的北京君正半導體有限公司估值報告中的分析暗示其股價相較於估計價值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300223 截至 2025 年 10 月的收益和收入增長</p>
<h2>Chroma ATE (TWSE:2360)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Chroma ATE Inc.是一家設計、組裝、製造、銷售、維修和維護各種軟件和硬件產品的公司，包括計算機自動測試系統和電子測試儀器，業務遍及台灣、中國、美國及國際市場；市值為 2931.8 億新台幣。</p>
<p><strong>運營：</strong> 公司的收入主要來自其測量儀器業務，產生 397.7 億新台幣，以及自動化運輸工程，貢獻 13.2 億新台幣。</p>
<p><strong>內部持股比例：</strong> 14.6%</p>
<p>Chroma ATE 的增長軌跡通過預計年收益增長 19.24% 得以體現，超過台灣市場的平均水平。儘管近期股價波動較大，但其 2025 年第二季度的強勁財務表現——收入上升至 64.6 億新台幣，淨收入達到 19.5 億新台幣——顯示出韌性。儘管內部交易活動保持穩定，沒有顯著的買入或賣出，但公司在三年內保持 32.5% 的強勁股本回報率預期。</p>
<ul>
<li>在我們的詳細增長預測報告中深入瞭解 Chroma ATE 的具體情況。</li>
<li>根據我們最近的估值報告，Chroma ATE 的交易價格似乎超出了其估計價值。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown"/></p>
<p>TWSE:2360 截至 2025 年 10 月的持股結構</p>
<h2>利用機會</h2>
<ul>
<li>點擊這裏解鎖我們全面的 819 家高內部持股的快速增長全球公司的名單。</li>
<li>準備好不同的方式了嗎？人工智能即將改變醫療保健。這 33 只股票正在從早期診斷到藥物發現的各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前入場。</li>
</ul>
<p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式引用，時間範圍為 1-3 年。</em></p>

鋭明技術

微導納米

北京君正

<p>在 2025 年 10 月，全球市場正經歷低於預期的美國通脹和波動的國債收益率，這促使投資者關注內部持股比例較高的成長型公司。值得注意的公司包括鋭明技術、Seers Technology 和 KebNi，內部持股比例在 11.9% 到 36.3% 之間，盈利增長在 24.9% 到 91.9% 之間。江蘇微導納米和北京君正儘管股價波動，但顯示出強勁的增長潛力。文章強調了內部持股作為不確定經濟條件下穩定因素的重要性</p>

<p>In October 2025, global markets are navigating a complex landscape marked by lower-than-expected U.S. inflation, fluctuating Treasury yields, and strengthening business activity across key regions such as the Eurozone and China. Amid these developments, investors are increasingly focusing on growth companies with high insider ownership as a potential avenue for stability and resilience in an uncertain economic environment.</p>
<div class="lb-trans"><p>在 2025 年 10 月，全球市場正面臨一個複雜的局面，特點是美國通脹低於預期、國債收益率波動，以及歐元區和中國等關鍵地區的商業活動增強。在這些發展中，投資者越來越關注內部持股比例高的成長型公司，作為在不確定經濟環境中尋求穩定和韌性的潛在途徑。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership Globally</h3>
<div class="lb-trans"><h3>全球內部持股比例高的十大成長型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.9%</td>
<td>43.9%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34.2%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>69.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>49.6%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股比例</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>鋭明技術 (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.9%</td>
<td>43.9%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34.2%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>69.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>49.6%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 819 stocks from our Fast Growing Global Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們篩選出的 819 只內部持股比例高的快速成長全球公司的完整名單。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>以下是我們篩選出的部分股票。</p>
</div><h2>Jiangsu Leadmicro Nano-Equipment Technology (SHSE:688147)</h2>
<div class="lb-trans"><h2>江蘇微導納米設備科技 (SHSE:688147)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Jiangsu Leadmicro Nano-Equipment Technology Ltd specializes in manufacturing high-end micro-nano equipment for semiconductor and pan-semiconductor industries, with a market cap of CN¥24.40 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 江蘇微導納米設備科技有限公司專注於製造高端微納米設備，服務於半導體及泛半導體行業，市值為 244 億元人民幣。</p>
</div><p><strong>Operations:</strong> The company generates revenue of CN¥2.96 billion from its equipment manufacturing segment, focusing on high-end micro-nano equipment for semiconductor and pan-semiconductor sectors.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司通過設備製造部門產生收入，專注於半導體及泛半導體領域的高端微納米設備。</p>
</div><p><strong>Insider Ownership:</strong> 18.7%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 18.7%</p>
</div><p>Jiangsu Leadmicro Nano-Equipment Technology exhibits strong growth potential, with earnings forecasted to increase significantly over the next three years. The company's revenue is expected to grow at 22.7% annually, outpacing the Chinese market average. Despite a high price-to-earnings ratio of 68.7x, it remains below the semiconductor industry average of 80.6x. Recent financial performance shows substantial improvement, with net income rising to CNY 192.36 million for H1 2025 from CNY 42.85 million last year, underscoring its growth trajectory amidst volatile share prices and completed share buybacks totaling CNY 79.53 million.</p>
<div class="lb-trans"><p>江蘇微導納米設備科技展現出強勁的增長潛力，預計未來三年收益將顯著增長。公司的收入預計將以 22.7% 的年率增長，超過中國市場的平均水平。儘管市盈率高達 68.7 倍，但仍低於半導體行業的平均水平 80.6 倍。最近的財務表現顯示出顯著改善，2025 年上半年淨收入從去年的 4285 萬元上升至 1.9236 億元，突顯出其在股價波動和完成總計 7953 萬元的股票回購中的增長軌跡。</p>
</div><ul>
<li>Navigate through the intricacies of Jiangsu Leadmicro Nano-Equipment Technology with our comprehensive analyst estimates report here.</li>
<li>Insights from our recent valuation report point to the potential overvaluation of Jiangsu Leadmicro Nano-Equipment Technology shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的綜合分析師估計報告深入瞭解江蘇微導納米設備科技的複雜性。</li>
<li>我們最近的估值報告指出，江蘇微導納米設備科技的股票在市場上可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/b4b45422-b4d0-4f2a-8c1b-61597995333c/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:688147 Earnings and Revenue Growth as at Oct 2025</p>
<div class="lb-trans"><p>SHSE:688147 截至 2025 年 10 月的收益和收入增長</p>
</div><h2>Ingenic SemiconductorLtd (SZSE:300223)</h2>
<div class="lb-trans"><h2>北京君正半導體有限公司 (SZSE:300223)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Ingenic Semiconductor Co., Ltd. focuses on the research, development, design, and sale of integrated circuit chip products both in China and internationally, with a market cap of CN¥43.42 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京君正半導體有限公司專注於集成電路芯片產品的研發、設計和銷售，業務覆蓋中國及國際市場，市值為 434.2 億元人民幣。</p>
</div><p><strong>Operations:</strong> Ingenic Semiconductor Co., Ltd. generates revenue through the research, development, design, and sale of integrated circuit chip products across domestic and international markets.</p>
<div class="lb-trans"><p><strong>運營：</strong> 北京君正半導體有限公司通過在國內外市場的集成電路芯片產品的研發、設計和銷售產生收入。</p>
</div><p><strong>Insider Ownership:</strong> 16%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 16%</p>
</div><p>Ingenic Semiconductor Ltd. demonstrates potential with earnings projected to grow significantly at 26.43% annually, surpassing the Chinese market average. However, its share price has been highly volatile recently. Despite this volatility, recent amendments to company bylaws and plans for an H-share offering in Hong Kong suggest strategic growth initiatives. The company's half-year 2025 financials show modest revenue and net income increases to CNY 2.25 billion and CNY 203.12 million respectively, indicating steady performance amidst these developments.</p>
<div class="lb-trans"><p>北京君正半導體有限公司展現出潛力，預計收益將以 26.43% 的年率顯著增長，超過中國市場的平均水平。然而，其股價近期波動較大。儘管如此，最近對公司章程的修訂和在香港進行 H 股發行的計劃表明了戰略增長的舉措。公司的 2025 年半年度財務數據顯示，收入和淨收入分別小幅增長至 22.5 億元和 2.0312 億元，表明在這些發展中的穩定表現。</p>
</div><ul>
<li>Take a closer look at Ingenic SemiconductorLtd's potential here in our earnings growth report.</li>
<li>The analysis detailed in our Ingenic SemiconductorLtd valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的收益增長報告中更深入地瞭解北京君正半導體有限公司的潛力。</li>
<li>我們的北京君正半導體有限公司估值報告中的分析暗示其股價相較於估計價值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/acde7488-b0a5-45e4-9f1d-446e3fdc5877/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300223 Earnings and Revenue Growth as at Oct 2025</p>
<div class="lb-trans"><p>SZSE:300223 截至 2025 年 10 月的收益和收入增長</p>
</div><h2>Chroma ATE (TWSE:2360)</h2>
<div class="lb-trans"><h2>Chroma ATE (TWSE:2360)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Chroma ATE Inc. is a company that designs, assembles, manufactures, sells, repairs, and maintains various software and hardware products including computerized automatic test systems and electronic test instruments across Taiwan, China, the United States, and internationally; it has a market cap of NT$293.18 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Chroma ATE Inc.是一家設計、組裝、製造、銷售、維修和維護各種軟件和硬件產品的公司，包括計算機自動測試系統和電子測試儀器，業務遍及台灣、中國、美國及國際市場；市值為 2931.8 億新台幣。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Measuring Instruments Business, which generates NT$39.77 billion, and Automated Transport Engineering, contributing NT$1.32 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其測量儀器業務，產生 397.7 億新台幣，以及自動化運輸工程，貢獻 13.2 億新台幣。</p>
</div><p><strong>Insider Ownership:</strong> 14.6%</p>
<div class="lb-trans"><p><strong>內部持股比例：</strong> 14.6%</p>
</div><p>Chroma ATE's growth trajectory is underscored by a forecasted earnings increase of 19.24% annually, outpacing the Taiwan market average. Despite recent share price volatility, its robust financial performance in Q2 2025—highlighted by revenue rising to TWD 6.46 billion and net income reaching TWD 1.95 billion—demonstrates resilience. While insider trading activity remains stable with no significant buying or selling, the company maintains a strong Return on Equity forecast of 32.5% in three years.</p>
<div class="lb-trans"><p>Chroma ATE 的增長軌跡通過預計年收益增長 19.24% 得以體現，超過台灣市場的平均水平。儘管近期股價波動較大，但其 2025 年第二季度的強勁財務表現——收入上升至 64.6 億新台幣，淨收入達到 19.5 億新台幣——顯示出韌性。儘管內部交易活動保持穩定，沒有顯著的買入或賣出，但公司在三年內保持 32.5% 的強勁股本回報率預期。</p>
</div><ul>
<li>Dive into the specifics of Chroma ATE here with our thorough growth forecast report.</li>
<li>In light of our recent valuation report, it seems possible that Chroma ATE is trading beyond its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的詳細增長預測報告中深入瞭解 Chroma ATE 的具體情況。</li>
<li>根據我們最近的估值報告，Chroma ATE 的交易價格似乎超出了其估計價值。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/0015e6b6-6fe9-4a56-9d8e-dc84ebdc9313/chart/ownership-breakdown"/></p>
<p>TWSE:2360 Ownership Breakdown as at Oct 2025</p>
<div class="lb-trans"><p>TWSE:2360 截至 2025 年 10 月的持股結構</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用機會</h2>
</div><ul>
<li>Unlock our comprehensive list of 819 Fast Growing Global Companies With High Insider Ownership by clicking here.</li>
<li>Ready For A Different Approach? AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏解鎖我們全面的 819 家高內部持股的快速增長全球公司的名單。</li>
<li>準備好不同的方式了嗎？人工智能即將改變醫療保健。這 33 只股票正在從早期診斷到藥物發現的各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前入場。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式引用，時間範圍為 1-3 年。</em></p>
</div>

2025 年 10 月內部持股比例高的全球增長型公司